Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

An Electronic Evaluation of Symptoms in People of India Post-COVID-19 Vaccination

Author(s): Sweta Kamboj*, Rohit Kamboj, Shikha Kamboj, Rohit Dutt, Kumar Guarve, Kamal Bansal and Vivek Rohila

Volume 18, Issue 1, 2023

Published on: 20 May, 2022

Page: [51 - 61] Pages: 11

DOI: 10.2174/1574886317666220328154358

Price: $65

Abstract

Background: Remarkable and groundbreaking performances of scientists all over the globe have led to the evolution of COVID-19 vaccines, which are extensively viewed as means to control the epidemic. The primary purpose of this research work was to discover the major side effects of the vaccines, mainly in Homo sapiens.

Methods: An online survey was conducted in various cities of Haryana, India, using a trial version of QualtricsCoreXM software to prototype 20 questionnaires.

Results: In the survey, 200 candidates participated, among which 83.5% had received Covishield and 16.5% had been vaccinated with Covaxin. Overall 65% of respondents have reported side effects. The major side effects reported were fever, tiredness, myalgia, diarrhea, headache, etc.

Conclusion: Succeeding the survey related to the effects of COVID-19 vaccine on non-identical Homo sapiens, generally with respect to their perspective regarding the symptoms of vaccine, both the vaccines were found to have mild side effects which could be easily managed.

Keywords: Vaccine, epidemic, COVID-19, side effects, symptoms, Covaxin.

« Previous Next »
Graphical Abstract

[1]
Kuter BJ, Browne S, Momplaisir FM, et al. Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in philadelphia. Vaccine 2021; 39(12): 1693-700.
[http://dx.doi.org/10.1016/j.vaccine.2021.02.029] [PMID: 33632563]
[2]
Sweta K, Rohit K, Shikha K, Kumar G, Rohit D. Novel coro-navirus 2019 outbreak: A global epidemic. Lett Drug Des Discov 2020; 17(12): 1458-64.
[http://dx.doi.org/10.2174/1570180817999200802033916]
[3]
Manning ML, Gerolamo AM, Marino MA, Hanson-Zalot ME, Pogorzelska-Maziarz M. COVID-19 vaccination readiness among nurse faculty and student nurses. Nurs Outlook 2021; 69(4): 565-73.
[http://dx.doi.org/10.1016/j.outlook.2021.01.019] [PMID: 33610324]
[4]
WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations. Available from: https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vacci
[5]
Coronavirus (COVID-19) vaccinations-statistics and research. Available from: data.org/covid-vaccinations
[6]
Holder J. Tracking coronavirus vaccinations around the world. The New York Times. Available from: https://www.nytimes.com/interactive/2021/world/covid-vaccinations-trackerhtml
[7]
Vaccine information. ICMR new delhi - COVID-19 vaccine. Available from: https://vaccine.icmr.org.in/covid-19-vaccine
[8]
Sherman SM, Smith LE, Sim J, et al. COVID-19 vaccination intention in the UK: Results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother 2021; 17(6): 1612-21.
[http://dx.doi.org/10.1080/21645515.2020.1846397] [PMID: 33242386]
[9]
Pulcini C, Leibovici L. CMI guidance for authors of surveys. Clin Microbiol Infect 2016; 22(11): 901-2.
[http://dx.doi.org/10.1016/j.cmi.2016.08.015] [PMID: 27599691]

Rights & Permissions Print Cite
Article Metrics
4
© 2024 Bentham Science Publishers | Privacy Policy